ISIN | LU2760217294 |
---|---|
Valor Number | 132611359 |
Bloomberg Global ID | UBSEHGQ LX |
Fund Name | UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) (GBP) Q-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Global Asset Management Basel Phone: +41 61 288 20 20 |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Fund’s investment objective consists in generating strong capital appreciation with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. This sub-fund is a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least two thirds of its assets worldwide in shares or other equity interests of companies in developed or emerging markets, which mainly promote United Nations Sustainable Development Goal 3 (Good Health and Well-Being). The focus is on companies that capitalise on healthcare transformation. |
Peculiarities |
Current Price * | 94.11 GBP | 02.07.2025 |
---|---|---|
Previous Price * | 93.84 GBP | 01.07.2025 |
52 Week High * | 110.50 GBP | 06.02.2025 |
52 Week Low * | 90.64 GBP | 23.05.2025 |
NAV * | 94.11 GBP | 02.07.2025 |
Issue Price * | 94.11 GBP | 02.07.2025 |
Redemption Price * | 94.11 GBP | 02.07.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 166,913,778 | |
Unit/Share Assets *** | 1,463,838 | |
Trading Information SIX |
YTD Performance | -6.39% |
31.12.2024 - 02.07.2025
31.12.2024 02.07.2025 |
---|---|---|
YTD Performance (in CHF) | -10.84% |
31.12.2024 - 02.07.2025
31.12.2024 02.07.2025 |
1 month | +1.26% |
02.06.2025 - 02.07.2025
02.06.2025 02.07.2025 |
3 months | -4.36% |
02.04.2025 - 02.07.2025
02.04.2025 02.07.2025 |
6 months | -7.74% |
02.01.2025 - 02.07.2025
02.01.2025 02.07.2025 |
1 year | -8.07% |
02.07.2024 - 02.07.2025
02.07.2024 02.07.2025 |
2 years | -5.34% |
23.02.2024 - 02.07.2025
23.02.2024 02.07.2025 |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 9.01% | |
---|---|---|
AstraZeneca PLC | 7.07% | |
UnitedHealth Group Inc | 5.84% | |
Intuitive Surgical Inc | 5.38% | |
Alcon Inc | 5.22% | |
Sandoz Group AG Registered Shares | 4.89% | |
Koninklijke Philips NV | 4.85% | |
Chugai Pharmaceutical Co Ltd | 4.41% | |
Novartis AG Registered Shares | 4.28% | |
Bristol-Myers Squibb Co | 4.26% | |
Last data update | 31.05.2025 |
TER | 1.06% |
---|---|
TER date | 30.11.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.73% |
Ongoing Charges *** | 0.98% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |